Showing 20 of 10299 recruiting trials
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
👨⚕️ Jean-Bernard AULIAC, Centre Hospitalier Intercommunal de Créteil Service Pneumologie📍 27 sites📅 Started Jun 2025View details ↗
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RecruitingNCT05819385 ↗
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
RecruitingNCT06955910 ↗
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Enrolling by InvitationNCT07094776 ↗
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
👨⚕️ Enes S Coşkun, M.D., University of Health Sciences, Gaziosmanpaşa Training and Research Hospital📍 1 site📅 Started Jun 2025View details ↗
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
👨⚕️ Santiago Cabezas, M.D., Ph.D., Hospital San Carlos, Madrid📍 11 sites📅 Started Jun 2025View details ↗
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
👨⚕️ Erin K Barr, Pediatric Early Phase Clinical Trial Network📍 17 sites📅 Started Jun 2025View details ↗
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
👨⚕️ Abhay Singh, MD, MPH, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07111663 ↗
An Observational Study of Individuals With Isolated Dystonia
RecruitingNCT07133464 ↗
CDH1-associated Blepharocheilodontic Syndrome Registry
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 3 sites📅 Started Jun 2025View details ↗
Enrolling by InvitationNCT06786754 ↗
Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases
RecruitingNCT07344480 ↗
Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →